NLRP3 and metabolic dysfunction-associated steatotic liver disease: This evidence has tightly linked inflammasome activation with lipid metabolism in NAFLD, suggesting the involvement of NLRP3 inflammasome in driving the progression of NAFLD and the significance of blocking NLRP3 inflammasome for the treatment of NAFLD.